JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2004; 44:2185-2191, doi:10.1016/j.jacc.2004.08.059
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elhendy, A.
Right arrow Articles by Porter, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elhendy, A.
Right arrow Articles by Porter, T. R.

CARDIAC IMAGING

Comparative accuracy of real-time myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress echocardiography for the diagnosis of coronary artery disease

Abdou Elhendy, MD, PhD, FACC*, Edward L. O'Leary, MD, FACC*, Feng Xie, MD*, Anna C. McGrain, BSN, RN*, James R. Anderson, PhD{dagger} and Thomas R. Porter, MD, FACC*,*

* Department of Internal Medicine, Section of Cardiology, University of Nebraska Medical Center, Omaha, Nebraska
{dagger} Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska

Manuscript received May 6, 2004; accepted August 25, 2004.

* Reprint requests and correspondence: Dr. Thomas R. Porter, 981165 Nebraska Medical Center, Omaha, Nebraska 68198-1165 (Email: trporter{at}unmc.edu).


    Abstract
 Top
 Abstract
 Methods
 Results
 Discussion
 Summary and conclusions
 References
 
OBJECTIVE: This study sought to compare the accuracy of myocardial contrast echocardiography (MCE) and wall motion analysis (WMA) during submaximal and peak dobutamine stress echocardiography (DSE) for the diagnosis of coronary artery disease (CAD).

BACKGROUND: The relative merits of MCE and WMA for the detection of CAD during DSE have not been studied in a large number of patients.

METHODS: We studied 170 patients who underwent dobutamine (up to 50 µg/kg/min)-atropine stress testing and coronary angiography. The WMA and MCE (using repeated boluses of Optison [Mallinckrodt, St. Louis, Missouri] or Definity [Bristol-Myers Squibb, New York, New York]) were performed at rest, at intermediate stress (65% to 75% of maximal heart rate), and at peak stress. The diagnosis of CAD (≥50% stenosis in ≥1 coronary artery) was based on reversible wall motion and perfusion abnormalities.

RESULTS: Coronary artery disease was detected in 127 (75%) patients. Sensitivity of MCE was higher than that of WMA at maximal stress (91% vs. 70%; p = 0.001) and at intermediate stress (84% vs. 20%; p = 0.0001). Specificity was lower for MCE compared with WMA (51% vs. 74%; p = 0.01). Overall accuracy was higher for MCE than for WMA (81% vs. 71%; p = 0.01). Sensitivity for detection of CAD based on abnormalities in ≥2 vascular regions was higher for MCE than for WMA (67% vs. 28%; p < 0.01).

CONCLUSIONS: The majority of inducible perfusion abnormalities occur at an intermediate phase of the stress test, without wall motion abnormalities. Myocardial contrast echocardiography provides better sensitivity than WMA, particularly in patients with submaximal stress and in identifying patients with multivessel CAD.

Abbreviations and Acronyms
  CAD = coronary artery disease
  CI = confidence interval
  DSE = dobutamine stress echocardiography
  ECG = electrocardiogram
  LAD = left anterior descending
  LCx = left circumflex
  MCE = myocardial contrast echocardiography
  RCA = right coronary artery
  WMA = wall motion analysis


Dobutamine stress echocardiography (DSE) is a widely used technique for the diagnosis of coronary artery disease (CAD). However, pooled data have shown that the sensitivity of wall motion analysis (WMA) is modest, particularly in patients with single-vessel CAD (1–7). Although patients with multivessel CAD often demonstrate wall motion abnormalities during DSE, abnormalities are often detected in a single vascular region, with underestimation of the extent of CAD (1).

The induction of new wall motion abnormalities during DSE is largely dependent on achieving an adequate stress level. Failure to achieve the predicted heart rate has been associated with false negative tests (1,5,8). Experimental studies have shown that myocardial perfusion abnormalities precede wall motion abnormalities during dobutamine infusion and, therefore, assessment of myocardial perfusion may potentially improve the sensitivity of DSE in patients with submaximal stress (9). Despite evidence from animal studies, the temporal sequence of perfusion and functional abnormalities in the ischemic cascade has not been adequately studied in humans.

Myocardial contrast echocardiography (MCE) is a newly introduced technique for the evaluation of myocardial perfusion in patients with suspected CAD (10–21). Real-time imaging using low mechanical index pulse sequence schemes enhances the detection of microbubbles and reduces microbubbles' destruction. This permits the real-time identification of perfusion abnormalities during stress echocardiography (21). The aims of this prospective study were: 1) to compare the accuracies of MCE and WMA during DSE for the overall and regional diagnosis of CAD; 2) to study the impact of achieved stress level on the accuracy of both methods; and 3) to document the temporal sequence of perfusion and wall motion abnormalities during myocardial ischemia in a large number of patients with suspected CAD.


    Methods
 Top
 Abstract
 Methods
 Results
 Discussion
 Summary and conclusions
 References
 
We prospectively studied 1,318 patients with known or suspected CAD, referred for DSE, by real-time MCE in conjunction with WMA in our institution between January 2000 and July 2003. Among these patients, 179 underwent coronary angiography within one month of DSE. Nine (5%) patients were excluded because of contrast attenuation during DSE that precluded adequate analysis of wall motion and perfusion. The final population, therefore, consisted of 170 patients. Mean age was 60 ± 12 years. There were 71 (42%) women. All patients gave an informed consent to undergo the stress test. The protocol of this study was approved by the Institutional Review Board of the University of Nebraska Medical Center. Clinical data are presented in Table 1.


View this table:
[in this window]
[in a new window]
 
Table 1. Clinical Data of the Study Patients
 
Dobutamine stress test.   Patients were instructed to discontinue beta-blockers 24 h before the stress test. Dobutamine was infused at a starting dose of 5 µg/kg/min for 3 to 5 min, followed by 10 µg/kg/min for 3 to 5 min. The dobutamine dose was increased by 10 µg/kg/min every 3 min up to a maximum dose of 50 µg/kg/min. Atropine (up to 2 mg) was administered intravenously if 85% of maximal predicted heart rate (220 – age) was not achieved. End points were achievement of target heart rate, maximal dose of dobutamine and atropine, hypertension (blood pressure >240/120 mm Hg), symptomatic decrease in systolic blood pressure, symptomatic or sustained ventricular or supraventricular tachycardia, ST-segment depression >2 mm in electrocardiogram (ECG) leads without resting ST-segment depression, >2 mm ST-segment elevation in ECG leads without Q waves, severe angina, and any intolerable adverse effect considered to be the result of dobutamine or atropine. Metoprolol (1 to 5 mg) was used intravenously to reverse the side effects of dobutamine if these did not revert quickly after termination of the infusion.

Echocardiographic imaging.   The contrast agents used for the study were a perfluorocarbon-containing, albumin-coated microbubble (Optison, Mallinckrodt, St. Louis, Missouri) in 140 patients and a lipid-encapsulated, perfluoropropane-filled microbubble (Definity, Bristol-Myers Squibb, New York, New York) in 30 patients. Imaging was performed using commercially available ultrasound scanners (Philips Agilent 5500 B.2 and Philips ATL HDI 5000 10.3.5, Philips Medical Systems, Bothell, Washington; or Siemens Acuson Sequoia 6.0, Siemens Medical Solutions, Malvern, Pennsylvania), equipped with low mechanical index, real-time pulse sequence schemes. Imaging was performed by the use of pulse-inversion Doppler (Philips ATL) in 109 (64%) patients, contrast pulse sequencing (Siemens Acuson Sequoia) in 30 (18%) patients, and power modulation (Philips Agilent) in 31 (18%) patients. The equipment was adjusted to achieve maximal nonlinear signal from contrast. Mechanical indexes were set to ≤0.3 and frame rate to ≥25 Hz. Time-gain compensation and two-dimensional gain settings were adjusted to suppress signals from the myocardium before contrast injection. Images from apical views (four-, two-, and three-chamber) were obtained and digitized at rest; at an intermediate stage of stress, defined as achievement of 65% to 75% of maximal heart rate predicted for age and at maximal stress after the patients had achieved ≥85% predicted maximum heart rate or a test end point.

After optimization of the settings, a 0.2- to 0.3-ml calibration dose of Optison or a 0.1- to 0.15-ml dose of Definity followed by a saline flush was given. Setting corrections were made to optimize gain and minimize any tissue nonlinear signals. Imaging began with a similar contrast dose in the apical four-chamber view. A minimum of 15 s of image acquisition was performed after peak myocardial opacification until disappearance of contrast from the myocardium. Imaging was acquired from the apical two-chamber and apical long axis views using the same method.

An independent investigator who had no knowledge of the clinical and angiographic data interpreted wall motion and perfusion using the 16-segment model (1). Studies were interpreted as either normal or abnormal in each of the three coronary arterial territories. A stress-induced contrast defect was considered present when two contiguous segments failed to exhibit contrast enhancement during the washout of contrast after the bolus injection compared with other segments at the same depth in the same view, and compared with contrast enhancement in the same segment at rest using a side-by-side image analysis. Attenuation from contrast or lung interference was considered present if any segment could not be visualized and was not distinguishable from surrounding tissue.

Wall motion was scored in each of the 16 segments as normal, hypokinetic, akinetic, or dyskinetic. A positive test for wall motion was defined as new or worsening wall motion abnormality in two or more contiguous segments during stress. The interobserver agreement in our laboratory is 84% for MCE and 91% for WMA (21). Intraobsever agreement was determined at intermediate and at peak stress for both WMA and MCE in 30 randomly selected patients. Results were presented as a percentage with a corresponding kappa value. To assess the accuracy of the independent reviewer for wall motion analysis of a standard DSE without contrast, 30 randomly selected patients who underwent standard DSE using the same infusion protocol and who had coronary angiography were evaluated.

The anterior septum, mid-posterior septum, anterior wall, and adjacent apical segments were assigned to the left anterior descending (LAD) coronary artery, lateral segments to the left circumflex (LCx) artery, and inferior and basal septal segments to the right coronary artery (RCA). The posterior wall was considered an overlap region and was assigned to either the LCx or RCA distribution. The apical inferior/posterior segments were also considered overlap regions and were assigned to the vascular territory with contiguous abnormalities.

Quantitative angiography.   Coronary angiography was performed within one month of DSE using the Judkins technique. Left ventriculography was performed to calculate ejection fraction. Quantitative measurements of coronary artery stenosis were made by an experienced interventional cardiologist (who had no knowledge of DSE results) using a hand-held electronic caliper (Tesa SA, Renens, Switzerland) (22). Measurements were expressed as the percent diameter narrowing, using the diameter of the nearest normal-appearing region as a reference. Coronary artery narrowings of ≥50% and ≥70% diameter were both used as cutoff values.

Statistical analysis.   Continuous variables were presented as mean and standard deviation and were compared using the Student t test. Sensitivity, specificity, and accuracy were calculated using standard definitions and were presented with 95% confidence intervals (CI). Comparison of proportions was made by the chi-square test. A p value <0.05 was considered significant.


    Results
 Top
 Abstract
 Methods
 Results
 Discussion
 Summary and conclusions
 References
 
Coronary angiography.   Coronary artery disease (≥50% stenosis) was detected in 127 (75%) patients. Among these patients, 32 had single-vessel, 50 had two-vessel, and 45 had three-vessel CAD. The remaining 43 patients had no significant CAD. Coronary artery stenoses involved the LAD in 101 (59%), the RCA in 82 (48%), and the LCx in 84 (49%) patients.

Dobutamine stress test.   Dobutamine-atropine induced significant changes in heart rate and rate pressure product (Table 2). Atropine was administered in 148 (87%) patients with a mean dose of 0.6 ± 0.5 mg. Chest pain occurred in 96 (56%) patients and ST-segment depression (>0.1 mV horizontal or downsloping) occurred in 32 (19%) patients. The target heart rate was achieved in 143 (84%) patients. Reasons for termination of the test in other patients were severe angina in eight patients, ST-segment changes in four patients, hypotension in one patient, and severe dyspnea in one patient. The test was not terminated because of wall motion or perfusion abnormalities in any patient.


View this table:
[in this window]
[in a new window]
 
Table 2. Hemodynamic Data at Different Stages of the Dobutamine Stress Test
 
New or worsening wall motion abnormalities occurred in 100 (59%) patients. Among these patients, 17 (17%) patients had resting abnormalities as well. New wall motion abnormalities were observed at intermediate stress in 27 patients. Inducible myocardial perfusion abnormalities occurred in 138 (81%) patients. These abnormalities were observed at intermediate stress in 119 (70%) patients. The intraobserver agreement on the presence or absence of reversible perfusion abnormality was 90% at intermediate stage (Kappa = 0.77) and 92% at peak stress (Kappa = 0.84). The intraobserver agreement on the presence or absence of inducible wall motion abnormality was 93% at intermediate stage (Kappa = 0.63) and 92% at peak stress (Kappa = 0.81).

Diagnostic accuracy of MCE and WMA.   Inducible myocardial perfusion abnormalities were detected in 116 of 127 patients with a ≥50% stenosis of ≥1 coronary artery and in 21 of 43 patients without a significant stenosis. New or worsening wall motion abnormalities were detected in 89 of 127 patients with ≥50% stenosis of ≥1 coronary artery and in 11 of 43 patients without a significant stenosis. Sensitivity, negative predictive value, and accuracy of MCE were significantly higher than for WMA. The difference in sensitivity was more striking at the intermediate stage. Specificity was higher for WMA (Table 3). The positive predictive value tended to be higher for WMA, but this difference did not reach statistical significance. Coronary artery disease was detected in 21 patients who received Definity and in 106 patients who received Optison. There was no significant difference between Optison and Definity with regard to sensitivity (92%, 95% confidence interval [CI] 0.87 to 0.98 vs. 86%, 95% CI 0.71 to 1.0), specificity (50%, 95% CI 0.33 to 0.67 vs. 56%, 95% CI 0.23 to 0.88), or accuracy (82%, 95% CI 0.76 to 0.89 vs. 77%, 95% CI 0.62 to 0.92).


View this table:
[in this window]
[in a new window]
 
Table 3. Overall Accuracy of Myocardial Contrast Echocardiography and Wall Motion Analysis for the Diagnosis of Coronary Artery Disease (≥50% Stenosis)
 
Diagnostic accuracy of MCE based on the echocardiographic system was 78% for Philips Agilent, 83% for Philips ATL, and 77% for Siemens Acuson Sequoia (p = NS).

Among the 30 randomly selected patients who underwent DSE without contrast, CAD was detected by angiography in 19. Sensitivity of WMA was 74% (95% CI 0.54 to 0.94), specificity was 82% (95% CI 0.59 to 0.97), and accuracy was 77% (95% CI 0.62 to 0.92).

Detection of multivessel CAD based on multivessel pattern of abnormalities.   Inducible perfusion abnormalities occurred more frequently in multivascular regions than did wall motion abnormalities (44% vs. 18%, p = 0.001). Defects were detected in ≥2 vascular distributions in 64 of 95 patients with multivessel CAD and in 10 of 75 patients without multivessel CAD (sensitivity = 67%, 95% CI 58 to 77; specificity = 87%, 95% CI 79 to 94; and accuracy = 76%, 95% CI 70 to 82). New or worsening wall motion abnormalities were detected in ≥2 vascular distributions in 27 of the 95 patients with multivessel CAD and in 3 of 75 patients without multivessel CAD (sensitivity = 28%, 95% CI 19 to 38, p < 0.001; specificity = 96%, 95% CI 92 to 99, p < 0.05; and accuracy = 58%, 95% CI 51 to 66, p < 0.001). Figure 1 presents echocardiographic images of a patient who developed perfusion defects in the LAD and LCx territories at the intermediate and peak stress stages, whereas wall motion was abnormal only in the LAD distribution at peak stress.



View larger version (66K):
[in this window]
[in a new window]
 
Figure 1 Echocardiographic images from the apical four-chamber and three-chamber views, at rest, intermediate stage (Intm), and peak stage of dobutamine stress in a patient with left anterior descending (LAD) and left circumflex (LCx) coronary artery disease (CAD). Perfusion abnormalities were evident in the lateral, posterior, and apical segments at intermediate phase with extension of these abnormalities at peak stress (arrows). The patient had inducible wall motion abnormalities confined to the apex at peak stress.

 
Regional accuracy.   Table 4 presents accuracy of both techniques for the regional diagnosis of CAD. Sensitivity and accuracy of MCE were significantly higher in all vascular regions. However, the difference in sensitivity was larger for RCA and LCx compared with the LAD territory. The majority of perfusion abnormalities occurred at an intermediate stage of DSE, often without wall motion abnormalities, resulting in a larger difference in sensitivities between both techniques at an intermediate as compared with peak stress. When CAD was defined as a ≥70% stenosis, sensitivity improved for each technique in all vascular regions. MCE maintained a higher sensitivity for diagnosis of RCA and LCx CAD, whereas sensitivity of both techniques for diagnosis of LAD stenosis was equally high (Table 4). Differences in regional sensitivity were narrower for stenoses ≥70% (22%) compared with stenoses between 50% and 69% (37%) (Fig. 2).


View this table:
[in this window]
[in a new window]
 
Table 4. Regional Accuracy of Myocardial Contrast Echocardiography and Wall Motion Analysis for the Diagnosis of Coronary Artery Disease in the Three Major Arterial Regions
 


View larger version (12K):
[in this window]
[in a new window]
 
Figure 2 Pooled regional sensitivities of wall motion analysis and myocardial contrast echocardiography for the diagnosis of coronary stenoses between 50% and 69% and ≥70%. Solid bars = perfusion; open bars = wall motion.

 

    Discussion
 Top
 Abstract
 Methods
 Results
 Discussion
 Summary and conclusions
 References
 
In this study, we compared the accuracy of WMA and MCE during DSE for the overall and regional diagnosis of CAD in 170 patients who underwent coronary angiography. The use of MCE resulted in a significant improvement in overall and regional sensitivity as well as negative predictive value for the diagnosis of CAD. Differences in sensitivity between both techniques were larger at the intermediate phase of the stress test. Although the specificity of WMA was higher, the overall accuracy and regional accuracy were significantly higher for MCE.

Impact of stress level on the sensitivity.   Failure to achieve the target heart rate has been reported as a cause of false negative DSE studies in patients with CAD (1,5,8). However, 10% to 20% of patients still fail to achieve the target heart rate because of premature termination of the test or inadequate chronotropic response (1,23). Myocardial perfusion abnormalities on radionuclide imaging have been detected in patients with CAD in the absence of wall motion abnormalities at a lower level of dobutamine stress (5,8,24,25).

Our study showed that reversible myocardial perfusion abnormalities could be detected in patients with CAD by real-time MCE. The majority of these abnormalities were observed without concomitant wall motion abnormalities at an earlier stage of the test. These findings would suggest that MCE can enhance the sensitivity and accuracy of DSE in patients who fail to achieve the target heart rate, as well as in patients in whom the test needs to be prematurely terminated because of side effects. Our study also emphasizes the concept of the ischemic cascade during demand stress in humans, in that inducible myocardial perfusion abnormalities preceded wall motion abnormalities during ischemia, as has already been shown in animal studies (9).

Recognition of multivessel CAD.   Recognition of multivessel CAD has important therapeutic and prognostic implications. Although the majority of patients with multivessel CAD demonstrate wall motion abnormalities during DSE, these abnormalities are frequently localized to one vascular region (1). The sensitivity of DSE for identifying multivessel CAD based on wall motion abnormalities in multivascular regions has ranged from 8% to 71% (1). In our study, MCE had a higher sensitivity for recognition of multivessel CAD (67% vs. 28%), with only a modestly lower specificity (87% vs. 96%) compared with WMA. These findings suggest that MCE may be a better method for evaluating the extent of CAD and predicting which patients have the largest functional area at risk.

Diagnostic accuracy in the three coronary arterial distributions.   Previous studies have demonstrated a modest sensitivity for DSE in diagnosing significant CAD in an individual coronary artery as well as in patients with single-vessel CAD (1–7). In this study, MCE had a significantly higher sensitivity and accuracy than WMA for the diagnosis of LAD, RCA, and LCx CAD. The difference in sensitivity was larger in the RCA and LCx regions. Previous studies have also confirmed the lower sensitivity of WMA in detecting isolated RCA or LCx disease when compared with isolated LAD disease (7). One explanation for the smaller differences in LAD sensitivity is the larger myocardial region subtended by LAD, which tends to make the identification of WMA less difficult. Leong-Poi et al. (9) studied nine dogs that underwent either single- or multivessel stenosis placement. In single-vessel stenosis, abnormal perfusion was seen at the lowest dose of dobutamine irrespective of the stenosis severity, whereas a wall motion abnormality was seen only at high doses of dobutamine and was influenced by the stenosis severity. The spatial extent of abnormal perfusion exceeded that of the wall motion abnormality at all but the highest dobutamine dose. Thus, the enhanced regional sensitivity we observed with MCE may be due to both the earlier occurrence of a perfusion defect and the greater size of any induced perfusion defect.

Impact of coronary artery stenosis severity.   When CAD was redefined as ≥70% stenosis, sensitivity was enhanced for both techniques in all arterial regions. Sensitivity of MCE remained higher than that of WMA for the diagnosis of LCx and RCA disease, whereas sensitivities for LAD CAD were no different. Pooled results in the three arterial regions showed a higher sensitivity for MCE for stenoses between 50% and 69% as well as for stenoses ≥70%. However, differences in regional sensitivity were smaller for stenoses ≥70% compared with stenoses between 50% and 69%. These data, as well as previous published reports, indicate that perfusion abnormalities during stress occur with less severe stenosis diameters than those that induce wall motion abnormalities (26,27). Animal studies have confirmed this phenomenon by demonstrating that dobutamine induces capillary derecruitment distal to a noncritical coronary stenosis, and that graded coronary stenoses result in a progressive reduction of myocardial blood flow ratios while wall thickening remains normal (28,29).

Study limitations.   Coronary angiography was performed according to the discretion of the treating physician and not per study protocol. The study patients represented only 13% of patients who underwent DSE. Therefore, results are heavily biased toward the selection process. This may explain the higher prevalence of CAD in the study patients and the lower specificity of MCE, because ischemia was more frequently detected by MCE, leading to more verification bias in association with perfusion abnormalities.

The lower specificity of MCE could also be due to artifactual defects in the apical and basal segments due to near field destruction and lung interference (30). Also, it is possible that impairment of vasodilator reserve may occur in the absence of a significant major coronary arterial narrowing. Although wall motion analysis was performed with the aid of contrast-enhanced border detection, which increases the number of segments that can be analyzed during DSE (31), the use of frame rates between 25 and 30 Hz may have decreased the ability of the reviewer to detect tardokinesis as a sign of ischemia (32).

Patients in this study had a high pre-test probability of CAD, reflected by 75% prevalence. This possibly contributed to a high sensitivity of MCE. The sensitivity of MCE may be lower in a population with lower disease prevalence.

Two different MCE agents were used, with potential differences in bubble concentration. However, adjustments were made in the dose administered to account for these differences, and a separate analysis of both agents revealed no difference in the diagnostic accuracy.

We used a small bolus injection technique to analyze myocardial perfusion. Unlike a continuous infusion of microbubbles, a bolus injection may have greater attenuation and will not be able to quantify myocardial blood flow changes (33). Most investigators consider the infusion method as the ideal way to achieve a "steady-state" microbubble concentration in the cavity pool and thus a constant input function. This also avoids the cavity attenuation that may occur when bolus injections are used at the higher cardiac outputs during staged dobutamine/atropine studies. However, with the very small bolus injections used in this study, we reduced the attenuation that occurs from left ventricular cavity contrast and had feasible image interpretation in 95% of patients. It is more likely that the majority of the attenuation problems were related to the low mechanical index pulse sequence schemes used for real-time imaging. Although a continuous infusion could potentially have improved the detection of coronary stenoses during dobutamine infusion, the reductions in myocardial blood volume alone from a coronary stenosis were sufficient to produce a significant improvement in accuracy using a simple bolus injection technique.


    Summary and conclusions
 Top
 Abstract
 Methods
 Results
 Discussion
 Summary and conclusions
 References
 
Real-time MCE improves the sensitivity and accuracy of DSE for the overall and regional diagnosis of CAD compared with WMA. The majority of reversible perfusion abnormalities in patients with CAD occur at the intermediate phase of the stress test, often without wall motion abnormalities, emphasizing the concept of an ischemic cascade during dobutamine stress in humans. Therefore, MCE will be particularly useful in patients who cannot achieve the target heart rate. The sensitivity of MCE is higher for detection of multivessel CAD based on abnormalities in ≥2 arterial regions, which can potentially improve the identification of high-risk patients. The findings of our study suggest that MCE should be the preferred method whenever the patient is anticipated not to achieve the target heart rate and in patients in whom the benefit of very high sensitivity outweighs the disadvantage of lower specificity, such as those with a pre-test probability of CAD higher than 50%. Future studies are needed to determine whether MCE can improve the prognostic value of DSE.


    References
 Top
 Abstract
 Methods
 Results
 Discussion
 Summary and conclusions
 References
 

  1. Geleijnse ML, Fioretti PM, Roelandt JR. Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography J Am Coll Cardiol 1997;30:595-606.[Abstract]
  2. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary articleA report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr 2003;16:1091-1110.[Medline]
  3. Elhendy A, Geleijnse ML, van Domburg RT, et al. Gender differences in the accuracy of dobutamine stress echocardiography for the diagnosis of coronary artery disease Am J Cardiol 1997;80:4-8.
  4. Ling LH, Pellikka PA, Mahoney DW, et al. Atropine augmentation in dobutamine stress echocardiography: role and incremental value in a clinical practice setting J Am Coll Cardiol 1996;28:551-557.[Abstract]
  5. Marwick T, D'Hondt AM, Baudhuin T, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol 1993;22:159-167.[Abstract]
  6. Salustri A, Fioretti PM, Pozzoli MM, McNeill AJ, Roelandt JR. Dobutamine stress echocardiography: its role in the diagnosis of coronary artery disease Eur Heart J 1992;13:70-77.[Abstract/Free Full Text]
  7. Elhendy A, van Domburg RT, Bax JJ, Poldermans D, Sozzi FB, Roelandt JR. Accuracy of dobutamine technetium 99m sestamibi SPECT imaging for the diagnosis of single-vessel coronary artery disease: comparison with echocardiography Am Heart J 2000;139:224-230.[Medline]
  8. Elhendy A, Geleijnse ML, Roelandt JR, et al. Dobutamine-induced hypoperfusion without transient wall motion abnormalities: less severe ischemia or less severe stress? J Am Coll Cardiol 1996;27:323-329.[Abstract]
  9. Leong-Poi H, Rim SJ, Le DE, Fisher NG, Wei K, Kaul S. Perfusion versus function: the ischemic cascade in demand ischemia: implications of single-vessel versus multivessel stenosis Circulation 2002;105:987-992.[Abstract/Free Full Text]
  10. Kaul S, Senior R, Dittrich H, Raval U, Khattar R, Lahiri A. Detection of coronary artery disease using myocardial contrast echocardiography: comparison with 99mTc-sestamibi single-photon emission computed tomography Circulation 1997;96:785-792.[Abstract/Free Full Text]
  11. Cwajg J, Xie F, O'Leary E, Kricsfeld D, Dittrich H, Porter TR. Detection of angiographically significant coronary artery disease with accelerated intermittent imaging after intravenous administration of ultrasound contrast material Am Heart J 2000;139:675-683.[Medline]
  12. Olszowska M, Kostkiewicz M, Tracz W, Przewlocki T. Assessment of myocardial perfusion in patients with coronary artery diseaseComparison of myocardial contrast echocardiography and 99mTc MIBI single-photon emission computed tomography. Int J Cardiol 2003;90:49-55.[CrossRef][Medline]
  13. Muro T, Hozumi T, Watanabe H, et al. Assessment of myocardial perfusion abnormalities by intravenous myocardial contrast echocardiography with harmonic power Doppler imaging: comparison with positron emission tomography Heart 2003;89:145-149.[Abstract/Free Full Text]
  14. Wei K. Approaches to the detection of coronary artery disease using myocardial contrast echocardiography Am J Cardiol 2002;90:48J-58J.[Medline]
  15. Porter TR, Xie F. Clinical experience in the detection of coronary artery disease with myocardial contrast echocardiography Echocardiography 2002;19:399-407.[CrossRef][Medline]
  16. Gunda M, Mulvagh SL. Recent advances in myocardial contrast echocardiography Curr Opin Cardiol 2001;16:231-239.[CrossRef][Medline]
  17. Laskar R, Grayburn PA. Assessment of myocardial perfusion with contrast echocardiography at rest and with stress: an emerging technology Prog Cardiovasc Dis 2000;43:245-258.[CrossRef][Medline]
  18. Mulvagh SL. Myocardial perfusion by contrast echocardiography: diagnosis of coronary artery disease using contrast-enhanced stress echocardiography and assessment of coronary anatomy and flow reserve Coron Artery Dis 2000;11:243-251.[CrossRef][Medline]
  19. Main ML, Escobar JF, Hall SA, Killam AL, Grayburn PA. Detection of myocardial perfusion defects by contrast echocardiography in the setting of acute myocardial ischemia with residual antegrade flow J Am Soc Echocardiogr 1998;11:228-235.[CrossRef][Medline]
  20. Kaul S. Myocardial contrast echocardiography Curr Probl Cardiol 1997;22:549-635.[CrossRef][Medline]
  21. Porter TR, Xie F, Silver M, Kricsfeld D, O'Leary E. Real-time perfusion imaging with low mechanical index pulse inversion Doppler imaging J Am Coll Cardiol 2001;37:748-753.[Abstract/Free Full Text]
  22. Uehata A, Matsuguchi T, Bittl JA, et al. Accuracy of electronic digital calipers compared with quantitative angiography in measuring coronary arterial diameter Circulation 1993;88:1724-1729.[Abstract/Free Full Text]
  23. Elhendy A, van Domburg RT, Bax JJ, et al. The functional significance of chronotropic incompetence during dobutamine stress test Heart 1999;81:398-403.[Abstract/Free Full Text]
  24. Geleijnse ML, Elhendy A, van Domburg RT, et al. Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest painEchocardiography, perfusion scintigraphy, or both?. Circulation 1997;96:137-147.[Abstract/Free Full Text]
  25. Geleijnse ML, Elhendy A. Can stress echocardiography compete with perfusion scintigraphy in the detection of coronary artery disease and cardiac risk assessment? Eur J Echocardiogr 2000;1:12-21.[Abstract/Free Full Text]
  26. Leistad E, Ohmori K, Peterson TA, Christensen G, DeMaria AN. Quantitative assessment of myocardial perfusion during graded coronary artery stenoses by intravenous myocardial contrast echocardiography J Am Coll Cardiol 2001;37:624-631.[Abstract/Free Full Text]
  27. Galiuto L, May-Newman K, Del Balzo U, Flaim SF, Iliceto S, DeMaria AN. Assessment of coronary stenoses of graded severity by myocardial contrast echocardiography J Am Soc Echocardiogr 2002;15:197-205.[CrossRef][Medline]
  28. Bin JP, Le DE, Jayaweera AR, Coggins MP, Wei K, Kaul S. Direct effects of dobutamine on the coronary microcirculation: comparison with adenosine using myocardial contrast echocardiography J Am Soc Echocardiogr 2003;16:871-879.[CrossRef][Medline]
  29. Bin JP, Pelberg RA, Wei K, Le DE, Goodman NC, Kaul S. Dobutamine versus dipyridamole for inducing reversible perfusion defects in chronic multivessel coronary artery stenosis J Am Coll Cardiol 2002;40:167-174.[Abstract/Free Full Text]
  30. Ay T, D'Hondt AM, Pasquet A, Melin JA, Vanoverschelde JL. Heterogeneity of contrast effect during intermittent second harmonic myocardial contrast echocardiography in healthy patients J Am Soc Echocardiogr 2002;15:1448-1452.[CrossRef][Medline]
  31. Mathias Jr. W, Arruda AL, Andrade JL, Filho OC, Porter TR. Endocardial border delineation during dobutamine infusion using contrast echocardiography Echocardiography 2002;19:109-114.[CrossRef][Medline]
  32. Mor-Avi V, Collins KA, Korcarz CE, Shah M, Spencer KT, Lang RM. Detection of regional temporal abnormalities in left ventricular function during acute myocardial ischemia Am J Physiol Heart Circ Physiol 2001;280:H1770-81.[Abstract/Free Full Text]
  33. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba D, Kaul S. Basis for detection of stenosis using venous administration of microbubbles during myocardial contrast echocardiography: bolus or continuous infusion? J Am Coll Cardiol 1998;32:252-260.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Eur J EchocardiogrHome page
O. Rana, R. Swallow, R. Senior, and K. Greaves
Detection of myocardial ischaemia caused by coronary artery-left ventricular fistulae using myocardial contrast echocardiography
Eur J Echocardiogr, August 4, 2008; (2008) jen215v1.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Dall'Armellina, T. M. Morgan, S. Mandapaka, W. Ntim, J. J. Carr, C. A. Hamilton, J. Hoyle, H. Clark, P. Clark, K. M. Link, et al.
Prediction of Cardiac Events in Patients With Reduced Left Ventricular Ejection Fraction With Dobutamine Cardiovascular Magnetic Resonance Assessment of Wall Motion Score Index
J. Am. Coll. Cardiol., July 22, 2008; 52(4): 279 - 286.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Kaul
Myocardial Contrast Echocardiography: A 25-Year Retrospective
Circulation, July 15, 2008; 118(3): 291 - 308.
[Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
M. Hacker, H. X. Hoyer, C. Uebleis, P. Ueberfuhr, S. Foerster, C. La Fougere, and H.-U. Stempfle
Quantitative assessment of cardiac allograft vasculopathy by real-time myocardial contrast echocardiography: a comparison with conventional echocardiographic analyses and [Tc99m]-sestamibi SPECT
Eur J Echocardiogr, July 1, 2008; 9(4): 494 - 500.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
F. Xie, S. Dodla, E. O'Leary, and T. R. Porter
Detection of Subendocardial Ischemia in the Left Anterior Descending Coronary Artery Territory With Real-Time Myocardial Contrast Echocardiography During Dobutamine Stress Echocardiography
J. Am. Coll. Cardiol. Img., May 1, 2008; 1(3): 271 - 278.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
P. A. Pellikka and S. L. Mulvagh
Echocardiography Contrast for Image Optimization: Beyond Confidence, It Is a Matter of Accuracy
J. Am. Coll. Cardiol. Img., March 1, 2008; 1(2): 153 - 155.
[Full Text] [PDF]


Home page
Eur Heart JHome page
S. A. Hayat and R. Senior
Myocardial contrast echocardiography in ST elevation myocardial infarction: ready for prime time?
Eur. Heart J., February 1, 2008; 29(3): 299 - 314.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. M. Tsutsui, F. Xie, D. Cloutier, S. Kalvaitis, A. Elhendy, and T. R. Porter
Real-time dobutamine stress myocardial perfusion echocardiography predicts outcome in the elderly
Eur. Heart J., February 1, 2008; 29(3): 377 - 385.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
R. Hoffmann, A. C. Borges, J. D. Kasprzak, S. von Bardeleben, C. Firschke, C. Greis, M. Engelhardt, H. Becher, and J. L. Vanoverschelde
Analysis of myocardial perfusion or myocardial function for detection of regional myocardial abnormalities. An echocardiographic multicenter comparison study using myocardial contrast echocardiography and 2D echocardiography
Eur J Echocardiogr, December 1, 2007; 8(6): 438 - 448.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
D. J. Rakhit, H. Becher, M. Monaghan, P. Nihoyannopoulis, and R. Senior
The clinical applications of myocardial contrast echocardiography
Eur J Echocardiogr, June 1, 2007; 8(3): s24 - s29.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. J. Bax, S. E. Inzucchi, R. O. Bonow, J. D. Schuijf, M. R. Freeman, E. J. Barrett, and on behalf of the Global Dialogue Group for the Eva
Cardiac Imaging for Risk Stratification in Diabetes
Diabetes Care, May 1, 2007; 30(5): 1295 - 1304.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. A. Dijkmans, R. Senior, H. Becher, T. R. Porter, K. Wei, C. A. Visser, and O. Kamp
Myocardial Contrast Echocardiography Evolving as a Clinically Feasible Technique for Accurate, Rapid, and Safe Assessment of Myocardial Perfusion: The Evidence So Far
J. Am. Coll. Cardiol., December 5, 2006; 48(11): 2168 - 2177.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A Elhendy, J M Tsutsui, E L O'Leary, F Xie, F Majeed, and T R Porter
Evaluation of restenosis and extent of coronary artery disease in patients with previous percutaneous coronary interventions by dobutamine stress real-time myocardial contrast perfusion imaging
Heart, October 1, 2006; 92(10): 1480 - 1483.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
A. Elhendy and T. R. Porter
Myocardial contrast quantitation during stress echocardiography
Eur J Echocardiogr, June 1, 2006; 7(3): 185 - 186.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. E. Weyman
The Year in Echocardiography
J. Am. Coll. Cardiol., February 21, 2006; 47(4): 856 - 863.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. M. Tsutsui, A. Elhendy, F. Xie, E. O'Leary, A. C. McGrain, and T. R. Porter
Reply
J. Am. Coll. Cardiol., November 15, 2005; 46(10): 1963 - 1964.
[Full Text] [PDF]


Home page
CirculationHome page
T. H. Marwick
Contrast Stress Echocardiography: Completing the Picture From Image Enhancement to Improved Accuracy and Prognostic Insight
Circulation, September 6, 2005; 112(10): 1382 - 1383.
[Full Text] [PDF]


Home page
CirculationHome page
J. M. Tsutsui, A. Elhendy, J. R. Anderson, F. Xie, A. C. McGrain, and T. R. Porter
Prognostic Value of Dobutamine Stress Myocardial Contrast Perfusion Echocardiography
Circulation, September 6, 2005; 112(10): 1444 - 1450.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J D Schuijf, L J Shaw, W Wijns, H J Lamb, D Poldermans, A de Roos, E E van der Wall, and J J Bax
Cardiac imaging in coronary artery disease: differing modalities
Heart, August 1, 2005; 91(8): 1110 - 1117.
[Full Text] [PDF]


Home page
Diabetes CareHome page
A. Elhendy, J. M. Tsutsui, E. L. O'Leary, F. Xie, A. C. McGrain, and T. R. Porter
Noninvasive Diagnosis of Coronary Artery Disease in Patients With Diabetes by Dobutamine Stress Real-Time Myocardial Contrast Perfusion Imaging
Diabetes Care, July 1, 2005; 28(7): 1662 - 1667.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. M. Tsutsui, A. Elhendy, F. Xie, E. L. O'Leary, A. C. McGrain, and T. R. Porter
Safety of dobutamine stress real-time myocardial contrast echocardiography
J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1235 - 1242.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Leong-Poi, M. P. Coggins, J. Sklenar, A. R. Jayaweera, X.-Q. Wang, and S. Kaul
Role of collateral blood flow in the apparent disparity between the extent of abnormal wall thickening and perfusion defect size during acute myocardial infarction and demand ischemia
J. Am. Coll. Cardiol., February 15, 2005; 45(4): 565 - 572.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, B. H. Greenberg, J. D. Knoke, K. U. Knowlton, W. Y.W. Lew, J. Narula, D. Sahn, et al.
Highlights of the year in JACC 2004
J. Am. Coll. Cardiol., January 4, 2005; 45(1): 137 - 153.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow